Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Hottest Industry Trends in Life Sciences Sector 2014

Published: Wednesday, April 23, 2014
Last Updated: Tuesday, April 22, 2014
Bookmark and Share
Meaningful “quick read” whitepaper “Life Science Trends 2014” also offers exclusive feature article on Big Data in the Life Sciences.

george james Ltd. has announced the availability of a new report “Life Science Trends 2014,” which outlines trends and innovations in the life sciences industry.

Written in conjunction with Carlyle Conlan, the report encompasses drugs, biologics, devices and diagnostics sectors, summarizing a variety of the most up to date industry news. It demonstrates significant advances in the industry from the past year and highlights observations about developments of interest throughout the year ahead.

Designed as a meaningful “quick read” whitepaper, the report is separated into several macro headers: Research and Innovation, Fundamental Trends, Investing and Deal Making, Regulatory and Government and Health Care.

The report is essential reading for those working in the pharmaceutical and biotech industries who are not only looking for an overall summary, but a resource to explore deeper, dependant on the individual interest of the reader.

In addition, the essential annual report also includes an exclusive feature article “Big Data in the Life Sciences”, which highlights commentary and interviews from several key senior industry professionals involved in big data breakthroughs in the life sciences sector.

This feature article demonstrates how the enormous increase in data volume from segments like sequencing and systems biology, coupled with trends in pre-competitive data sharing and advanced computing frameworks, is in the early stages of providing robust signals, that will ultimately decrease the cost of drug development and maximize the industry’s return on investment.

Neil Burns, Founding Director at george james Ltd, said: “We are very pleased that this report has been published and is now easily available to download from our website. It has been structured in a way which is easy to read for industry professionals in pharma and biotech to keep informed but still can be researched further. We at george james strive help our customers achieve their core goals and specialization and hope this report offers premium research of value to the life sciences sector.”

Don Alexander, Practice Head and Vice President, Life Sciences at Carlyle Conlan, comments: “We are very pleased to be able to, with the support of George James, have a report available for the public to read which covers such a wide range of articles across pertinent areas such as Health Care, Research and Innovation. What makes our report different is that an early version is sent to CEOs, venture capitalists and other industry experts for review before its final release and created using both primary and secondary data. We invite you to review the information contained in the report which we hope you will find relevant and interesting.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Point of Care Diagnostics - A Cautious Revolution
Advances in molecular biology, coupled with the miniaturization and improved sensitivity of assays and devices in general, have enabled a new wave of point-of-care (POC) or “bedside” diagnostics.
ReadCoor Launched to Commercialize 3D Sequencing Tech
ReadCoor will leverage the Wyss Institute’s method for simultaneously sequencing and mapping RNAs within cells and tissues to advance development of diagnostics.
Crispr Toolbox Expanded By Protein
Researchers have shown a newly discovered CRISPR protein has two distinct RNA cutting activities.
Heart Arrhythmia Caused by Mosaic of Mutant Cells
Researchers have solved the genetic mystery of an infant suffering from heart arrhythmia.
Over Two-Thirds of Cervical Cancer Deaths Prevented
Cervical screening prevents 70% of cervical cancer deaths and if all eligible women regularly attended screening this would rise to 83%.
Detecting Bacterial Infections in Newborns
Researchers tested an alternative way to diagnose bacterial infections in infants—by analyzing RNA biosignatures from a small blood sample.
Case for Liquid Biopsies Builds in Advanced Lung Cancer
Study addresses unmet need for better, non-invasive tests called out in recent "Moonshot" blue ribbon panel report
Mechanisms of Parkinson’s Pathology
Defects that lead to cells’ failure to decommission faulty mitochondria cause nerve cells to die, triggering the symptoms of Parkinson’s disease.
Genetic Misdiagnoses of Heart Condition
Analysis found several genetic variations previously linked with a heart condition were harmless, leading to condition misdiagnosis.
Opening Door to Oesophageal Cancer Targeted Treatments
Scientists have discovered that oesophageal cancer can be classified into three different subtypes.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!